Clinical validation of RCSMS: A rapid and sensitive CRISPR-Cas12a test for the molecular detection of SARS-CoV-2 from saliva is a research paper published in PLOS ONE (2024). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
Grant: 111-2020-FONDECYT
Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
Grant: 042-2020-FONDECYT
Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
Grant: 113-2020-FONDECYT
Spanish Agency for International Development Cooperation
Grant: AECID-504.2020
ISA REP
Grant: Private Funding
Essalud - IETSI
FWCI
1.46
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals